Fresenius Medical Completes Multicurrency Bond Offering
Date: 01/26/12
Cahill represented BofA Merrill Lynch, Deutsche Bank, Barclays Capital, J.P. Morgan, Scotia Capital and Wells Fargo Securities as joint lead managers and bookrunners and the other co-managers in connection with the Rule 144A/Reg S offering of $800,000,000 5.625% Senior Notes due 2019 and $700,000,000 5.875% Senior Notes due 2022 by Fresenius Medical Care US Finance II, Inc. Proceeds of the offering will be used for acquisitions, including the acquisition of Liberty Dialysis Holdings Inc., as well as to refinance existing debt and for general corporate purposes.
Cahill represented Deutsche Bank, BofA Merrill Lynch, Credit Agricole CIB and UniCredit Bank as joint lead managers and bookrunners and the other co-managers in connection with the €250,000,000 5.25% Senior Notes due 2019 by FMC Finance VIII S.A. The proceeds of the offering will be used for acquisitions, including the acquisition of Liberty Dialysis Holdings Inc., as well as to refinance existing debt and for general corporate purposes.